"Saltzer Health is a fast-growing, dynamic healthcare organization with clinics and urgent care locations in Nampa, Caldwell, Meridian & Boise. As the state’s largest independent medical group, our 60 providers offer services in family practice, internal medicine, pediatrics, OB/GYN & midwifery, orthopedics, general surgery, rheumatology, ENT, sleep medicine, ophthalmology, nephrology, behavioral health and other specialties. Founded by Dr. Joseph Saltzer in 1961, Saltzer Health provides quality health care with a focus on transparency and affordability with medical experts you know and trust."

During the past decade, Saltzer Medical Group conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saltzer Medical Group" #1 sponsor was "Pfizer" with 4 trials, followed by "Abbott Nutrition" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Shire" with 2 trials sponsored and "Akebia Therapeutics" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saltzer Medical Group" #1 collaborator was "Basilea Pharmaceutica" with 1 trials as a collaborator, "Cyclerion Therapeutics" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Saltzer Medical Group" are "Growth" (2 trials), "Respiratory Tract Infection" (2 trials), "Adenoviral Conjunctivitis" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Bacterial Conjunctivitis" (1 trials). Many other conditions were trialed in "Saltzer Medical Group" in a lesser frequency.

Most popular intervention types in "Saltzer Medical Group" are "Drug" (9 trials), "Other" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Control Infant Formula" (2 trials), "Experimental Infant Formula" (2 trials), "SHP640" (2 trials) and "13-valent pneumococcal conjugate vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saltzer Medical Group" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Saltzer Medical Group". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Saltzer Medical Group, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Saltzer Medical Group, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".